Financial Summary (All financials)
| In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 |
| Revenues | 1.9 | -0.2 | 0.6 | 0.5 | 0.5 | 0.0 | 0.3 | 0.7 |
| Revenue growth | -896.2% | -143.0% | 20.7% | -2.9% | | -100.0% | -56.6% | 149.0% |
| Cost of goods sold | 1.9 | -72.4 | 0.0 | -21.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 72.1 | 0.6 | 21.7 | 0.5 | 0.0 | 0.3 | 0.7 |
| Gross margin | 0.0% | -30061.8% | 100.0% | 4691.2% | 100.0% | | 100.0% | 100.0% |
| Research and development | 25.4 | 23.1 | 17.8 | 12.7 | 10.9 | 15.6 | 17.4 | 19.2 |
| General and administrative | 10.7 | 13.1 | 11.7 | 8.0 | 6.3 | 5.8 | 6.5 | 13.9 |
| EBITA | -36.0 | -36.2 | -28.9 | -20.2 | -16.7 | -21.4 | -23.6 | -32.3 |
| EBITA margin | -1885.6% | 15080.9% | -5178.8% | -4354.4% | -3503.7% | | -8282.2% | -4921.0% |
| Amortization of intangibles | 0.0 | | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| EBIT | -36.1 | -36.2 | -29.0 | -20.2 | -16.8 | -21.4 | -23.6 | -32.4 |
| EBIT margin | -1887.2% | 15080.9% | -5188.3% | -4364.1% | -3519.5% | | -8295.5% | -4927.2% |
| Pre-tax income | -36.7 | -36.4 | -30.3 | -22.1 | -31.8 | -14.4 | -11.5 | -34.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -37.6 | -36.7 | -30.3 | -22.1 | -31.9 | -14.4 | -11.5 | -34.7 |
| Net margin | -1969.2% | 15296.7% | -5419.5% | -4783.2% | -6683.7% | | -4038.7% | -5277.4% |
| |
| Diluted EPS | ($0.87) | ($0.90) | ($0.82) | ($0.71) | ($1.87) | ($1.83) | ($2.37) | ($10.51) |
| Shares outstanding (diluted) | 43.1 | 40.7 | 36.8 | 31.2 | 17.0 | 7.9 | 4.9 | 3.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|